Use a gentle cleanser and lukewarm water to cleanse the areas thoroughly
The experimental nature of microdosing carries unknown risks that could include reduced efficacy, unexpected side effects, or long-term complications
By Olivia Lockhart, Peptide Researcher & Analyst, 10+ years
University of Texas Southwestern Medical Center in Dallas
The first GLP-1 drug to receive FDA approval in 2005 was Amylin/Lilly's Byetta, administered as a twice-daily injection for the treatment of type 2 diabetes
As someone who has dedicated his career to understanding and treating alcohol use disorder, I recognize the significance of these findings, particularly given the current attention on the adverse health impact of heavy drinking, said Henry Kranzler, Professor of Psychiatry at the University of Pennsylvania Perelman School of Medicine and Principal Investigator of the RECLAIM trial